Global HIV/AIDS Clinical and Translational Pharmacology.
作者信息
Morse Gene D, Maartens Gary, Maponga Charles Chiedza, Ma Qing
机构信息
Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, NY 14260, USA.
出版信息
AIDS Res Treat. 2012;2012:973627. doi: 10.1155/2012/973627. Epub 2012 Jul 18.
Abstract
摘要
相似文献
1
Global HIV/AIDS Clinical and Translational Pharmacology.全球艾滋病毒/艾滋病临床与转化药理学
AIDS Res Treat. 2012;2012:973627. doi: 10.1155/2012/973627. Epub 2012 Jul 18.
2
Asia-inclusive global development of pevonedistat: Clinical pharmacology and translational research enabling a phase 3 multiregional clinical trial.在亚洲开展 pevonedistat 的全球开发：临床药理学和转化研究，为 3 期多区域临床试验提供支持。
Clin Transl Sci. 2021 May;14(3):1069-1081. doi: 10.1111/cts.12972. Epub 2021 Feb 2.
3
Introduction to a Special Issue of the Journal of Immunological Methods: Building global resource programs to support HIV/AIDS clinical trial studies.《免疫学方法杂志》特刊介绍：建立全球资源计划，以支持艾滋病毒/艾滋病临床试验研究。
J Immunol Methods. 2014 Jul;409:1-5. doi: 10.1016/j.jim.2014.05.016. Epub 2014 Jun 6.
4
The burden of HIV: insights from the Global Burden of Disease Study 2010.HIV 负担：来自 2010 年全球疾病负担研究的见解。
AIDS. 2013 Aug 24;27(13):2003-17. doi: 10.1097/QAD.0b013e328362ba67.
5
Global, regional, and national HIV/AIDS disease burden levels and trends in 1990-2019: A systematic analysis for the global burden of disease 2019 study.全球、区域和国家 1990-2019 年艾滋病毒/艾滋病疾病负担水平和趋势：全球疾病负担 2019 研究的系统分析。
Front Public Health. 2023 Feb 15;11:1068664. doi: 10.3389/fpubh.2023.1068664. eCollection 2023.
6
7
Osteoimmunopathology in HIV/AIDS: A Translational Evidence-Based Perspective.HIV/AIDS中的骨免疫病理学：基于循证医学的转化视角
Patholog Res Int. 2011;2011:359242. doi: 10.4061/2011/359242. Epub 2011 May 21.
8
The (Contrasted) Ethics of Covid-19 and HIV: Will the Favor be Returned?新冠病毒与艾滋病毒的（对比）伦理学：这份善意会得到回报吗？
J Healthc Sci Humanit. 2021 Fall;11(1):107-121.
10
Spatial and Temporal Trends in HIV/AIDS Burden Among Worldwide Regions From 1990 to 2019: A Secondary Analysis of the Global Burden of Disease Study 2019.1990年至2019年全球各地区艾滋病毒/艾滋病负担的时空趋势：全球疾病负担研究2019的二次分析
Front Med (Lausanne). 2022 May 12;9:808318. doi: 10.3389/fmed.2022.808318. eCollection 2022.
引用本文的文献
1
Strategies for Implementation Research to Investigate the Negative Pharmacokinetic Interaction Between Efavirenz and Dolutegravir.用于研究依非韦伦与多替拉韦之间负性药代动力学相互作用的实施研究策略。
Clin Infect Dis. 2021 May 18;72(10):1823-1825. doi: 10.1093/cid/ciaa982.
2
Clinical pharmacology quality assurance for HIV and related infectious diseases research.艾滋病病毒及相关传染病研究的临床药理学质量保证
Clin Pharmacol Ther. 2013 Jun;93(6):479-82. doi: 10.1038/clpt.2013.62. Epub 2013 Mar 26.
本文引用的文献
1
The safety, effectiveness and concentrations of adjusted lopinavir/ritonavir in HIV-infected adults on rifampicin-based antitubercular therapy.利福平为基础的抗结核治疗的 HIV 感染成年人中调整洛匹那韦/利托那韦的安全性、有效性和浓度。
PLoS One. 2012;7(3):e32173. doi: 10.1371/journal.pone.0032173. Epub 2012 Mar 7.
2
HIV prevention by oral preexposure prophylaxis.口腔暴露前预防（PrEP）进行艾滋病预防。
Cold Spring Harb Perspect Med. 2012 Mar;2(3):a007419. doi: 10.1101/cshperspect.a007419.
3
Effect of HIV-1 infection and sex on the cellular pharmacology of the antiretroviral drugs zidovudine and lamivudine.HIV-1 感染和性别对抗逆转录病毒药物齐多夫定和拉米夫定的细胞药代动力学的影响。
Antimicrob Agents Chemother. 2012 Jun;56(6):3011-9. doi: 10.1128/AAC.06337-11. Epub 2012 Mar 5.
4
Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women.奈韦拉平药代动力学与撒哈拉以南非洲地区 HIV 感染女性皮疹和肝炎风险。
AIDS. 2012 Apr 24;26(7):833-41. doi: 10.1097/QAD.0b013e328351a521.
5
HIV reservoirs and strategies for eradication.HIV 储库与清除策略。
Curr HIV/AIDS Rep. 2012 Mar;9(1):5-15. doi: 10.1007/s11904-011-0108-2.
6
Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapy.自我报告抗逆转录病毒治疗依从性差的 HIV 感染患者持续病毒抑制的决定因素。
PLoS One. 2012;7(1):e29186. doi: 10.1371/journal.pone.0029186. Epub 2012 Jan 3.
7
Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir.脑脊液中核苷酸 HIV 逆转录酶抑制剂替诺福韦浓度低。
J Acquir Immune Defic Syndr. 2012 Apr 1;59(4):376-81. doi: 10.1097/QAI.0b013e318247ec54.
8
Pharmacogenomics of HIV therapy: summary of a workshop sponsored by the National Institute of Allergy and Infectious Diseases.HIV治疗的药物基因组学：美国国立过敏与传染病研究所主办研讨会综述
HIV Clin Trials. 2011 Sep-Oct;12(5):277-85. doi: 10.1310/hct1205-277.
9
Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission.替诺福韦和恩曲他滨在黏膜组织中的渗透：对预防 HIV-1 传播的意义。
Sci Transl Med. 2011 Dec 7;3(112):112re4. doi: 10.1126/scitranslmed.3003174.
10
Pre-exposure prophylaxis for HIV prevention: how to predict success.用于预防HIV的暴露前预防：如何预测成功。
Lancet. 2012 Jun 30;379(9835):2409-2411. doi: 10.1016/S0140-6736(11)61852-7. Epub 2011 Dec 6.
Zotero 插件